Cal-X Stars Accelerator to Present Medtech Portfolio at Founders Club During JP Morgan Healthcare Conference
SANTA MONICA, Calif., Dec. 21, 2012 /PRNewswire/ -- The Cal-X Stars Business Accelerator www.calxstars.com, recently recognized by BizBest eMagazine as being one of the top accelerators in California, has announced it will present its 2013 class of medtech portfolio companies at The Founders Club DEMO Day at the San Francisco offices of Wilson Sonsini. This is the 2nd annual Founders Club Healthcare Life Science Demo Day event, which will coincide with the 32nd annual J.P. Morgan Healthcare Conference in San Francisco.
The Cal-X Stars 2013 portfolio of medtech and biotech companies to be presented January 8th, 2013 by Howard Leonhardt, Founder, Chairman & CEO:
Bioheart, Inc. www.bioheartinc.com - In Phase II/III trials stage in U.S. for muscle stem cells for treating advanced heart failure. Believed to be the only cell type able to create new contractile muscle in heart scar tissue. Phase II/III Part I interim results demonstrated 95.7 meters improvement in exercise capacity in Bioheart MyoCell patients over placebo (-4 meters) in a double blind randomized study. This compares to -4 meters for CHF drugs, 16 meters for CRT pacers, 53 meters for cardiac stem cells, 52 meters for adipose derived cells, 10 meters allogeneic bone marrow derived cells. (See Bioheart SEC Filings for risk factors).
MyoStim Pacers – www.myostimpacers.com - First heart pacemaker designed to recruit healing stem cells to heart tissue and to promote proliferation of resident cardiomyocytes and new blood vessel growth. A peripheral model is designed to accelerate healing of wounds such as diabetic foot ulcers and to improve blood flow in limbs. Company holds three issued pioneering patents including the landmark claim of the specific signal for converting pluripotent stem cells to beating heart muscle cells.
Stem Cell Bra – www.stemcellbra.com - World's first female bra designed to recruit her own stem cells from fat tissue and other sources to breast tissue for augmenting fullness and size without surgery. Utilizes a conductive gelatin bra liner connected to an electrical stimulator the size of a cell phone that produces a homing signal for stem cells in breast tissue via stimulation of SDF-1 protein release.
Heart Pump Cath – www.heartpumpcath.com - The first heart pump catheter developed in Germany by Cardiobridge will file for CE Mark commercial approval 3Q 2013 based on clinical trials conducted over the past 2 years. Clinical studies thus far have demonstrated a 33% improvement in cardiac output, substantially improved renal function and creatinine levels in acute decompensating heart failure patients.
BioPace – The world's first biological pacemaker made of living cells.
HeartScore – Do you know your Heart Score? The company has developed a single composite score combined with a real time monitoring wrist watch, SecondBeat, to guide people to be in compliance with diet, exercise and treatment regimes for lowering risks. The composite score is made up of genetic tests, blood tests including pioneering ischemia and inflammation panels, as well as an artery scan.
AortaCell – stem cells and a non-invasive abdominal belt with a wireless electrical energy pulse used to treat aortic aneurysms.
CoroStim – Vibrational energy utilized to inhibit plaque formation in high risk coronary arteries.
EndoCell – Endothelial progenitor cells derived from fat tissue injected into coronary arteries via an adventia delivery catheter for healing purposes.
MyoValve + Valvublator – stem cell seeding and scaffold support of heart valve leaflets post removal of calcification with the Valvublator catheter. Allows patient to keep their own heart valve instead of getting a transplant.
Andrew Romans, general partner and founder of The Founders Club commented, "Los Angeles, and Santa Monica in particular, is a hotbed of entrepreneurial activity harnessing the unique talent, creativity and energy of the region. We are working closely with the top individuals creating the most important technology companies including The Cal-X Stars Business Accelerator, Leonhardt Ventures and Cal-X The California Stock Xchange. We welcome the opportunity to showcase our portfolio companies and connect them to the Silicon Valley."
Founders Club events bring together CEOs, founders, VCs, LPs, angel investors, bankers and other important members of the venture capital ecosystem via demo days, conferences and networking events.
Location: Wilson Sonsini Goodrich & Rosati San Francisco / Soma 139 Townsend Street Suite 150 San Francisco, California 94107 Time: 4 to 7:30pm. Date: January 8th, 2013
To Attend Contact:
[email protected] or [email protected]
Cal-X Stars Business Accelerator – www.calxstars.com - is a business accelerator headquartered in Santa Monica, California. By design 50% of our portfolio will always be focused on medtech biotech, our central strength, with an emphasis on stem cell related technologies. The other 50% of the portfolio is made up of investments designed to provide cash flow to offset the slower developing biotech businesses. The Cal-X Stars Business Accelerator is directly tied via shared ownership and management to The California Stock Exchange www.calstockexchange.com (Cal-X) which has aspirations to become the 3rd leading stock exchange in the U.S. focused on serving small firms, particularly high growth tech companies (in early pre-registration stage with the SEC at this time). Cal-X does offer now a full range of services to help businesses grow step by step starting with their Cal-X EquityNet business plan analysis.
Cal-X Stars Business Accelerator a Leonhardt Ventures Company, 1531 6th Street, Unit 401, Santa Monica, CA 90401 – TEL: 310 310 2534 web sites: www.calxstars.com, www.calstockexchange.com and www.leonhardtventures.com. Contact: Howard Leonhardt Email: [email protected]
This news release was issued by PR Syndication.
SOURCE Cal-X Stars Business Accelerator
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article